Biotech company Orphazyme has been granted another new deadline for the release of its full-year 2021 report, the company has announced in a press release on Tuesday.
Upon request, the Danish Business Authority has approved an extension to the deadline for annual report’s filing, which follows the initiation of Orphazyme’s in-court restructuring proceedings.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
CHMP to remove 100 generic medicines from market
Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.
Germany orders 40,000 monkeypox vaccines from Bavarian Nordic
The German Minister for Health has revealed that the German state has ordered vaccines from Bavarian Nordic, as the country reports 5 cases of monkeypox.
Chemist for Incoming Materials in QC Department 
Quality System Manager 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Clinical Project Manager 
Strategic Procurement Manager, Direct Spend (Category Manager) 
System Sales Development Consultant - Investment Projects, Merck Millipore 
2 Sales Representatives and Product Specialists 
Analytical Senior Scientist 
Communications Consultant 
Clinical Trial Manager for development of in vitro diagnostics 
Production Director 
IRT Manager, Clinical Drug Supply 
Client Talent Acquisition Specialist 
(Senior) Drug Substance Specialist 
Senior Chemical Safety Advisor 
Director Global Engineering